Overview
Accounting from the recent liberalization, the North African country, Algeria has seen a steady growth in international and private pharmaceutical investments attracting medicine’s and medical device’s investors from all over the world. The Directorate of Pharmacy and Medicine oversee the registrations and licensing management for market access. However, lack of regional Regulatory expertise might challenge foreign manufacturer’s compliance efforts in the region.
Freyr, as a global Regulatory partner, assists foreign manufacturers not only by providing comprehensive Regulatory affairs services, but also by offering time-critical Regulatory operations assistance. Freyr’s Regulatory services in Algeria span across:
- Medical Devices
- Pharmaceuticals
- OTC
- Biotech
- Natural Medicines
Freyr Offerings
- Strategic Regulatory consulting
- Regulatory affairs & Regulatory intelligence
- Registration pathways and license management services
- Marketing authorizations
- Regulatory submissions
- Regulatory labeling and artwork services
Freyr Advantages
- Strategic and well-versed local regulatory knowledgebase – with M.O.H, National Laboratory for the Control of Pharmaceutical Products (LNCPP)
- Expert Regulatory team with proven global RA expertise
- Proactive and Collaborative approach
- Quick turnarounds and faster time-to-market
- Keeping abreast with region-specific legislation and Regulatory guidelines